A phase 2 trial suggests myostatin inhibition may reduce lean body mass loss during tirzepatide treatment while maintaining overall weight reduction.
In a clinical trial, an experimental antibody reduced lean-mass loss in people on a GLP-1 drug. Whether that improves health ...
Trial suggests monoclonal antibody can help retain lean body mass when losing weight with GLP-1 medicines ...
FITCHBURG, Mass., June 10, 2026 /PRNewswire/ -- Millions of Americans are turning to GLP-1 medications such as Zepbound ®, ...
You may yet be able to lean out without losing out, as a new drug could save GLP-1 users from the flat fate of “Ozempic butt.
CicadaBio today announced that new preclinical data for CC-18, its investigational GLP-1/anti-ActRII dual-pathway fusion protein, were shared during an oral presentation at the American Diabetes ...
A phase 2 trial found that apitegromab plus tirzepatide reduced lean body mass loss by 1.9 kg compared with tirzepatide plus ...
Omega-3 fatty acids are bioactive nutrients with the potential to preserve lean body mass in individuals with cancer. This study aimed to review the literature on randomized clinical trials that ...
Research links women's lean body mass with how quickly they eliminate alcohol from their system. Women with obesity and those who are older eliminate alcohol from their bloodstreams faster than those ...
Digital anthropometry by three-dimensional optical imaging systems and smartphones has recently been shown to provide non-invasive, precise, and accurate anthropometric and body composition ...
The rate at which women eliminate alcohol from their bloodstream is largely predicted by their lean body mass, although age plays a role, too, scientists found in a new study. Women with obesity—and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results